Home » Raw 264.7 Whole Cell - T0901317 treated Products

We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Register on R&D Systems

Raw 264.7 Whole Cell - T0901317 treated Products

Kits
Raw 264.7 Whole Cell - T09013 ...
Raw 264.7 Whole Cell - T0901317 tr...
NBP1-30159
Western Blot Raw 264.7 Whole Cell - T0901317 treated Assay Kit
Applications: WB
Read More
See All Raw 264.7 Whole Cell - T0901317 treated Products
We have 1 Raw 264.7 Whole Cell - T0901317 treated Kit
Lysates
Raw 264.7 Whole Cell - T09013 ...
Raw 264.7 Whole Cell - T0901317 tr...
NBP1-30158
Western Blot Raw 264.7 Whole Cell - T0901317 treated Whole Cell Lysate
Species: Mu
Applications: WB
Read More
See All Raw 264.7 Whole Cell - T0901317 treated Products
We have 1 Raw 264.7 Whole Cell - T0901317 treated Lysate

Description

Treatment with liver X receptor (LXR) agonists like benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide], or more commonly known as T0901317 (T09), lowers the cholesterol level in serum and liver and inhibits the development of atherosclerosis in murine disease models. T09 modulates cholesterol metabolism and inhibits inflammation.